Are your patients properly anticoagulated?

It’s Not Just Support. It’s Solutions.

Measuring Warfarin in Patients

with a Lupus Anticoagulant

Throughout last year, the use of DOACs in patients with antiphospholipid antibody syndrome (aPS) has been debated. Here we address two key questions:

• What are the options for monitoring a patient with the presence of a strong LA inhibitor, where INRs might be unreliable?
• What test can measure the effect of warfarin to help ensure the patient is in therapeutic range?

The chromogenic Factor X assay can be used here to measure % Factor X (FX) levels. Chromogenic FX activity levels have shown utility for monitoring warfarin therapy in patients where INR is unreliable, such as in aPS.

The DiaPharma Factor X Kit is accessible, FDA cleared, and offered by reference labs across the U.S.

Visit diapharma.com to learn more.

Reference: Rosborough T.K., Shepherd M.F. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy. 2004;24(7):838–842.

View our full portfolio of hemostasis and thrombosis assays at diapharma.com.

It’s Not Just Support. It’s Solutions.

Over 25 years of scientific expertise, just a call or click away.

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846

ML-01-00015Rev01